These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6765402)

  • 21. Expression of 4C8 antigen, a novel transendothelial migration-associated molecule on activated T lymphocytes, in inflammatory bowel disease.
    Oshitani N; Hato F; Kitagawa S; Masuyama J; Higuchi K; Matsumoto T; Arakawa T
    J Pathol; 2002 Aug; 197(5):589-94. PubMed ID: 12210077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced serum levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in patients with inflammatory bowel disease.
    Hoffmann JC; Göke MN; Evers J; Räuker HJ; Bayer B; Manns MP
    Z Gastroenterol; 1996 Sep; 34(9):522-7. PubMed ID: 8873455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
    Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
    Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crohn's ileitis in a patient with longstanding HIV infection.
    Bernstein BB; Gelb A; Tabanda-Lichauco R
    Am J Gastroenterol; 1994 Jun; 89(6):937-9. PubMed ID: 7911001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4+NKG2D+ T cells in Crohn's disease mediate inflammatory and cytotoxic responses through MICA interactions.
    Allez M; Tieng V; Nakazawa A; Treton X; Pacault V; Dulphy N; Caillat-Zucman S; Paul P; Gornet JM; Douay C; Ravet S; Tamouza R; Charron D; Lémann M; Mayer L; Toubert A
    Gastroenterology; 2007 Jun; 132(7):2346-58. PubMed ID: 17570210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcome of patients examined by capsule endoscopy for suspected small bowel Crohn's disease.
    Girelli CM; Porta P; Malacrida V; Barzaghi F; Rocca F
    Dig Liver Dis; 2007 Feb; 39(2):148-54. PubMed ID: 17196893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
    J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An increased number of CD40-high monocytes in patients with Crohn's disease.
    Sawada-Hase N; Kiyohara T; Miyagawa J; Ueyama H; Nishibayashi H; Murayama Y; Kashihara T; Nakahara M; Miyazaki Y; Kanayama S; Nezu R; Shinomura Y; Matsuzawa Y
    Am J Gastroenterol; 2000 Jun; 95(6):1516-23. PubMed ID: 10894589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
    Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel disease.
    Shinzaki S; Iijima H; Nakagawa T; Egawa S; Nakajima S; Ishii S; Irie T; Kakiuchi Y; Nishida T; Yasumaru M; Kanto T; Tsujii M; Tsuji S; Mizushima T; Yoshihara H; Kondo A; Miyoshi E; Hayashi N
    Am J Gastroenterol; 2008 May; 103(5):1173-81. PubMed ID: 18177457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children.
    Herrero-Morín JD; Málaga S; Fernández N; Rey C; Diéguez MA; Solís G; Concha A; Medina A
    Crit Care; 2007; 11(3):R59. PubMed ID: 17519026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Improvement of bone metabolism after infliximab therapy in Crohn's disease].
    Miheller P; Muzes G; Zágoni T; Tóth M; Rácz K; Tulassay Z
    Orv Hetil; 2005 Jul; 146(28):1477-80. PubMed ID: 16130441
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin G subclasses in Crohn's disease with and without bowel resection.
    Bures J; Tichý M; Horácek J; Král B; Sobotka L; Cervenka B; Zadák Z; Komárková O; Fixa B; Pidrman V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):139-47. PubMed ID: 8159910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
    Mir A; Minguez M; Tatay J; Pascual I; Peña A; Sanchiz V; Almela P; Mora F; Benages A
    Am J Gastroenterol; 2002 Jun; 97(6):1452-7. PubMed ID: 12094864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.